Derek R. McHaffie, MD

Derek R. McHaffie, MD

workRadiation Oncologist
location_onAtrium Health – Levine Cancer Institute – CMC Radiation Therapy Center

About Dr. McHaffie

Board Certification

May 2, 2012

Licensure

North Carolina

South Carolina

Professional Organizations

ASCO (American Society of Clinical Oncology)

ASTRO (American Society for Therapeutic Radiology and Oncology)

ACR (American College of Radiology)

ACRO (American College of Radiation Oncology)

ABS (American Brachytherapy Society)

AOA (Alpha Omega Alpha)


Awards & Affiliations


Education

University of Wisconsin Hospital and Clinics Radiation Oncology

2007 — 2011

Madison, WI

Residency

East Tennessee State University College of Medicine

2002 — 2006

Johnson City, TN

M.D.

University of Tennessee

1988 — 2002

Knoxville, TN

College Scholars Program, concentration in English literature, Spanish, and Biology


Employment

Internship, University of Wisconsin Hospital and Clinics

2006

Madison, WI


Publications

Find Dr. MvHaffie’s full list of publications on PubMed here.


Books

Book Chapters

  • McHaffie DR, Khuntia D, Suh JH, Tomé WA, Mehta MP. Chapter 17. Stereotactic Irradiation: Linear Accelerator and Gamma Knife. In: Gunderson and Tepper, eds. Clinical Radiation Oncology. 3rd ed. October 2011.

Selected Meeting Presentations

  • Carolinas College of Health Sciences, Radiation Therapy Seminar, Charlotte, NC, January 12th, 2013. “Principles of Head and Neck Cancer Management.”
  • 32nd Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 12th, 2009. Poster Discussion. “Outcomes following Accelerated Partial Breast Irradiation in Patients with ASTRO Consensus Statement Unsuitable Features.”
  • 51st Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Chicago, IL, November 4th, 2009. Oral Presentation. “Outcomes following Accelerated Partial Breast Irradiation in Patients with ASTRO Consensus Statement Cautionary Features.”
  • Annual Meeting of the Wisconsin Society of Radiation Oncology, Milwaukee, WI, May 2nd, 2009. Oral Presentation. “Hypofractionation for Prostate Cancer: Rationale, Technique, and Outcomes.”

Abstracts

  • Platta, CS, Bayliss A, McHaffie DR, Straub M, Bradley KA. Dosimetric Evaluation of TomoTherapy based Whole Pelvic Intensity Modulated Radiation Therapy with and without Bone Marrow Sparing in Gynecologic Cancers. Int J Radiat Oncol Biol Phys. 2011. Oct 1; 81 Supp. (2): S465.
  • Thomas SR, Kruser TJ, Gondi V, McHaffie DR, Straub MR, and Bradley KA. Patterns of First Recurrence after Adjuvant Radiotherapy in Papillary Serous and Clear Cell Carcinoma of the Uterus. 51st Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, CA, October 30th, 2010.
  • McHaffie DR, Patel RR, Geye HM, Das RK, Cannon GM. Outcomes following Accelerated Partial Breast Irradiation in
    Patients with ASTRO Consensus Statement Unsuitable Features. Cancer Research. 2009. Dec 15; 69 Supp. (24): S536.
  • McHaffie DR, Patel RR, Adkison JB, Das RK, Cannon GM. Outcomes following Accelerated Partial Breast Irradiation in
    Patients with ASTRO Consensus Statement Cautionary Features. Int J Radiat Oncol Biol Phys. 2009. Oct 1; 75 Supp. (3): S76
  • McHaffie DR, Adkison JB, Patel RR, Khuntia D, Ritter MA. Analysis of Rectal Bleeding Risk with Hypofractionated Radiation Therapy for Clinically Localized Prostate Cancer. Am J Clin Oncol. 2009. Feb 1; 32 (1): 108.
  • McHaffie DR, Patel RR, Khuntia D, Adkison JB, Ritter MA. Hypofractionated Radiation Therapy for Clinically Localized Prostate Cancer – 70 Gy at 2.5 Gy per Fraction Revisited. Int J Radiat Oncol Biol Phys. 2008. Sept 1; 72 Supp. (1): S316-7.
  • Adkison JB, Patel RR, Bentzen SM, Hong TS, McHaffie DR, Ritter MA. Pelvic Nodal Dose Escalation in Conjunction with Hypofractionated IMRT for High Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2008. Sept 1; 72 Supp (1): S305.
  • Campbell SE, McHaffie D, Whaley S, Stone WL, Krishnan K. Differences in the ability ofalpha- and gamma- tocopherol to suppress deoxycholic acid induced expression of cyclooxygenase-2 protein in HCT-116 and HT-29 human colon cancer cell lines. 2nd Annual American Association of Cancer Research International Conference “Frontiers in Cancer Prevention Research.” Phoenix, AZ, October 26-30, 2003.